Literature DB >> 35093536

Novel mechanistic insight on the neuroprotective effect of berberine: The role of PPARδ for antioxidant action.

Jia-Wen Shou1, Xiao-Xiao Li2, Yun-Sang Tang1, Bobby Lim-Ho Kong1, Hoi-Yan Wu2, Meng-Jie Xiao1, Chun-Kai Cheung1, Pang-Chui Shaw3.   

Abstract

Cerebral ischemic stroke ranks the second leading cause of death and the third leading cause of disability in lifetime all around the world, urgently necessitating effective therapeutic interventions. Reactive oxygen species (ROS) have been implicated in stroke pathogenesis and peroxisome proliferator-activated receptors (PPARs) are prominent targets for ROS management. Although recent research has shown antioxidant effect of berberine (BBR), little is known regarding its effect upon ROS-PPARs signaling in stroke. The aim of this study is to explore whether BBR could target on ROS-PPARs pathway to ameliorate middle cerebral artery occlusion (MCAO)-induced stroke. Herein, we report that BBR is able to scavenge ROS in oxidation-damaged C17.2 neural stem cells and stroked mice. PPARδ, rather than PPARα or PPARγ, is involved in the anti-ROS effect of BBR, as evidenced by the siRNA transfection and specific antagonist treatment data. Further, we have found BBR could upregulate NF-E2 related factor-1/2 (NRF1/2) and NAD(P)H:quinone oxidoreductase 1 (NQO1) following a PPARδ-dependent manner. Mechanistic study has revealed that BBR acts as a potent ligand (Kd = 290 ± 92 nM) to activate PPARδ and initiates the transcriptional regulation functions, thus promoting the expression of PPARδ, NRF1, NRF2 and NQO1. Collectively, our results indicate that BBR confers neuroprotective effects by activating PPARδ to scavenge ROS, providing a novel mechanistic insight for the antioxidant action of BBR.
Copyright © 2022 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Berberine; PPARδ; ROS; Stroke

Mesh:

Substances:

Year:  2022        PMID: 35093536     DOI: 10.1016/j.freeradbiomed.2022.01.022

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  2 in total

Review 1.  Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms.

Authors:  Jia-Wen Shou; Pang-Chui Shaw
Journal:  Cells       Date:  2022-02-24       Impact factor: 6.600

Review 2.  The Role of Concomitant Nrf2 Targeting and Stem Cell Therapy in Cerebrovascular Disease.

Authors:  Jonah Gordon; Gavin Lockard; Molly Monsour; Adam Alayli; Cesario V Borlongan
Journal:  Antioxidants (Basel)       Date:  2022-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.